# Sublobar Resection Versus Lobectomy for cT1N0M0 Non-small-cell Lung Cancer

> **NCT03108560** · NA · UNKNOWN · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 600 (estimated)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **PROCEDURE:** sublobar resection
- **PROCEDURE:** lobectomy

## Key facts

- **NCT ID:** NCT03108560
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-18
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2018-09-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03108560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03108560, "Sublobar Resection Versus Lobectomy for cT1N0M0 Non-small-cell Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03108560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*